FDA Inspection 1190720 — Creative Testing Solutions

Creative Testing Solutions — FEI 1000140241

The FDA completed an inspection of Creative Testing Solutions on November 3, 2022 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 3, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Charlotte, NC (United States)